Cardiology
Products
Cardiology
Products
Cardiology
Products
CARDALISTM is the safe, FDA-approved, once-a-day, unique combination for the management of congestive heart failure (CHF) in dogs. Studies show that CARDALISTM is more effective than an ACE inhibitor alone with fewer cardiac deaths, treatment failures, and signs of CHF. A chewable combination of spironolactone and benazepril, CARDALISTM provides an easy, palatable way to accomplish quadruple therapy for CHF (as recommended by the ACVIM in the 2019 consensus guidelines for the diagnosis and treatment of MMVD in dogs). (*reference the ACVIM guidelines document here)
See below for the reference information for the ACVIM guidelines:
Keene, BW, Atkins, CE, Bonagura, JD, et al. ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs. J Vet Intern Med. 2019; 33: 1127– 1140. https://doi.org/10.1111/jvim.15488